Skip to main content
. 2021 Mar 30;9:656741. doi: 10.3389/fcell.2021.656741

FIGURE 7.

FIGURE 7

Disease-free survival (DFS) and overall survival (OS) of patients with breast cancer by lymph vessel invasion status in the neoadjuvant chemotherapy (NACT) group. (A,B) Kaplan-Meier analysis of the DFS (A) and OS (B) of breast cancer patients by lymph vessel invasion status in NACT group. (C,D) Kaplan-Meier analysis of the DFS (C) and OS (D) of patients without lymph vessel invasion by prognostic nutritional index (PNI) in NACT group. (E,F) Kaplan-Meier analysis of the DFS (E) and OS (F) of patients with lymph vessel invasion by PNI in NACT group.